Historique
Bulletin de Périodique
International Journal of Drug Policy , Vol.24, n°2 - March 2013
Paru le :
01/03/2013
Article en page(s) :
85-165
Langue(s) :
Anglais
Note de contenu :
CONTENTS:
• Review and meta-analysis of the association between self-reported sharing of needles/syringes and hepatitis C virus prevalence and incidence among people who inject drugs in Europe. Palmateer N.E., Hutchinson S.J., Innes H., Schnier C., Wu O., Goldberg D.J., et al., p. 85-100.
• Interdisciplinary mixed methods research with structurally vulnerable populations: Case studies of injection drug users in San Francisco. Lopez A.M., Bourgois P., Wenger L.D., Lorvick J., Martinez A.N., Kral A.H., p. 101-109.
• The Doping Myth: 100 m sprint results are not improved by 'doping'. Hermann A., Henneberg M., p. 110-114.
• Are suppression and deterrence mechanisms enough? Examining the “pulling levers” drug market intervention strategy in Peoria, Illinois, USA. Corsaro N., Brunson R.K., p. 115-121.
• Is law enforcement of drug-impaired driving cost-efficient? An explorative study of a methodology for cost–benefit analysis. Veisten K., Houwing S., Mathijssen M.P.M., Akhtar J., p. 122-134.
• Injection drug users' and their risk networks' experiences of and attitudes towards drug dealer violence in Baltimore, Maryland. Latkin C.A., Yang C., Tobin K.E., German D., p. 135-141.
• Patterns of cocaine and opioid co-use and polyroutes of administration among street-based cocaine users in Montréal, Canada. Roy É., Richer I., Arruda N., Vandermeerschen J., Bruneau J., p. 142-149.
• Socio-demographic factors, health risks and harms associated with early initiation of injection among people who inject drugs in Tallinn, Estonia: Evidence from cross-sectional surveys. Vorobjov S., Des Jarlais D.C., Abel-Ollo K., Talu A., Rüütel K., Uusküla A., p. 150-155.
• Design considerations for supervised consumption facilities (SCFs): Preferences for facilities where people can inject and smoke drugs. Watson T.M., Strike C., Kolla G., Penn R., Jairam J., Hopkins S., et al., p. 156-163.
• The development of methadone maintenance treatment in the Maldives. Chengappa M.N., Rao R., Suresh Kumar M., p. 164-165.
• Review and meta-analysis of the association between self-reported sharing of needles/syringes and hepatitis C virus prevalence and incidence among people who inject drugs in Europe. Palmateer N.E., Hutchinson S.J., Innes H., Schnier C., Wu O., Goldberg D.J., et al., p. 85-100.
• Interdisciplinary mixed methods research with structurally vulnerable populations: Case studies of injection drug users in San Francisco. Lopez A.M., Bourgois P., Wenger L.D., Lorvick J., Martinez A.N., Kral A.H., p. 101-109.
• The Doping Myth: 100 m sprint results are not improved by 'doping'. Hermann A., Henneberg M., p. 110-114.
• Are suppression and deterrence mechanisms enough? Examining the “pulling levers” drug market intervention strategy in Peoria, Illinois, USA. Corsaro N., Brunson R.K., p. 115-121.
• Is law enforcement of drug-impaired driving cost-efficient? An explorative study of a methodology for cost–benefit analysis. Veisten K., Houwing S., Mathijssen M.P.M., Akhtar J., p. 122-134.
• Injection drug users' and their risk networks' experiences of and attitudes towards drug dealer violence in Baltimore, Maryland. Latkin C.A., Yang C., Tobin K.E., German D., p. 135-141.
• Patterns of cocaine and opioid co-use and polyroutes of administration among street-based cocaine users in Montréal, Canada. Roy É., Richer I., Arruda N., Vandermeerschen J., Bruneau J., p. 142-149.
• Socio-demographic factors, health risks and harms associated with early initiation of injection among people who inject drugs in Tallinn, Estonia: Evidence from cross-sectional surveys. Vorobjov S., Des Jarlais D.C., Abel-Ollo K., Talu A., Rüütel K., Uusküla A., p. 150-155.
• Design considerations for supervised consumption facilities (SCFs): Preferences for facilities where people can inject and smoke drugs. Watson T.M., Strike C., Kolla G., Penn R., Jairam J., Hopkins S., et al., p. 156-163.
• The development of methadone maintenance treatment in the Maldives. Chengappa M.N., Rao R., Suresh Kumar M., p. 164-165.
Exemplaires
| Disponibilité |
|---|
| aucun exemplaire |
Dépouillements
Ajouter le résultat à votre sélection
N. E. PALMATEER ;
S. J. HUTCHINSON ;
H. INNES ;
C. SCHNIER ;
O. WU ;
D. J. GOLDBERG ;
M. HICKMAN
|
2013
Dans International Journal of Drug Policy (Vol.24, n°2, March 2013) Article : Périodique
Dans International Journal of Drug Policy (Vol.24, n°2, March 2013) Article : Périodique
BACKGROUND: Although sharing needles/syringes (N/S) is a recognised risk factor for the hepatitis C virus (HCV), epidemiological studies have shown inconsistent associations between self-reported N/S sharing and biological markers of HCV infecti[...]
A. M. LOPEZ ;
P. BOURGOIS ;
L. D. WENGER ;
J. LORVICK ;
A. N. MARTINEZ ;
A. H. KRAL
|
2013
Dans International Journal of Drug Policy (Vol.24, n°2, March 2013) Article : Périodique
Dans International Journal of Drug Policy (Vol.24, n°2, March 2013) Article : Périodique
Research with injection drug users (IDUs) benefits from interdisciplinary theoretical and methodological innovation because drug use is illegal, socially sanctioned and often hidden. Despite the increasing visibility of interdisciplinary, mixed [...]
N. CORSARO ;
R. K. BRUNSON
|
2013
Dans International Journal of Drug Policy (Vol.24, n°2, March 2013) Article : Périodique
Dans International Journal of Drug Policy (Vol.24, n°2, March 2013) Article : Périodique
BACKGROUND: Police agencies across the globe enforce laws that prohibit drug transportation, distribution, and use with varying degrees of effectiveness. Within the United States, law enforcement strategies that rely on partnerships between crim[...]
K. VEISTEN ;
S. HOUWING ;
M. P. M. MATHIJSSEN ;
J. AKHTAR
|
2013
Dans International Journal of Drug Policy (Vol.24, n°2, March 2013) Article : Périodique
Dans International Journal of Drug Policy (Vol.24, n°2, March 2013) Article : Périodique
BACKGROUND: Road users driving under the influence of psychoactive substances may be at much higher relative risk (RR) in road traffic than the average driver. Legislation banning blood alcohol concentrations above certain threshold levels combi[...]
E. ROY ;
I. RICHER ;
N. ARRUDA ;
J. VANDERMEERSCHEN ;
J. BRUNEAU
|
2013
Dans International Journal of Drug Policy (Vol.24, n°2, March 2013) Article : Périodique
Dans International Journal of Drug Policy (Vol.24, n°2, March 2013) Article : Périodique
BACKGROUND: Effective public health programs aimed at problematic cocaine users are challenged by the fact that they can have complex patterns of drug use with respect to polysubstance use and routes of drug administration. This study was carrie[...]
T. M. WATSON ;
C. STRIKE ;
G. KOLLA ;
R. PENN ;
J. JAIRAM ;
S. HOPKINS ;
J. LUCE ;
N. DEGANI ;
P. MILLSON ;
A. M. BAYOUMI
|
2013
Dans International Journal of Drug Policy (Vol.24, n°2, March 2013) Article : Périodique
Dans International Journal of Drug Policy (Vol.24, n°2, March 2013) Article : Périodique
BACKGROUND: Supervised consumption facilities (SCFs) aim to improve the health and well-being of people who use drugs by offering safer and more hygienic alternatives to the risk environments where people typically use drugs in the community. Pe[...]